Scancell Holdings is trading 5.05% up at £10.40, although no clear company-specific announcement dated September 9, 2026 was identified.
- The latest reported items were a September 3 investor presentation and an August 19 Phase 3 trial authorization update.
- The broader market was weaker while Scancell moved higher, leaving the catalyst unclear.
- Trading activity appears limited; one reported September 8 transaction involved 25,276 shares.